Raxibacumab: Monoclonal Antibody for Inhalational Anthrax

Raxibacumab is a human IgG1 monoclonal antibody designed to treat and prevent inhalational anthrax caused by Bacillus anthracis. It targets the protective antigen component of the anthrax toxin, inhibiting its binding to cellular receptors and preventing toxin entry. Administered via IV infusion, Ra

0 views • 6 slides